Pregnancy

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia® (denosumab), to treat a variety of...

Gelatide Drops Under Investigation: Full Gelatide-1 Consumer Report Reveals Shocking Hidden Risks & Fake Gelatin Trick Recipe

A 2026 informational consumer evaluation of Gelatide marketing claims, ingredient research context, Akkermansia muciniphila and proprietary blend dosage transparency, the...

Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting

Arizona Femtech Startup Prickly Pear Health Expands Pre-Seed Funding to more than $600K With Investment From Emmeline Ventures

Women-led venture firm joins existing investors to accelerate growth of AI-powered brain health platform for womenPHOENIX, March 26, 2026 /PRNewswire/...

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

David Meeker Quote David Meeker Quote Dr. Shoemaker quote Dr. Shoemaker quote IMCIVREE packaging IMCIVREE packaging with vial IMCIVREE 3D...

Carrot Presents AI-Powered Metabolic-Fertility Research at National Conference on Women’s Health Hosted by the U.S. Department of Health and Human Services

New research introduces Sprints — the first program to combine generative AI with continuous wearable biometrics to optimize metabolic health...

error: Content is protected !!